Skip to main content
Equibles
ELUT logo

ELUT · Elutia Inc. · Metrics

Track ELUT — free

Use ELUT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELUT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.83 +0.00 (+0.33%)
Rebalance outlook locked
Market Cap
$36.44M
Shares
44.29M
Volume · Oct 22 2708 Avg daily vol (3M) 176.53K

ELUT metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.82
Market cap
$36.44M

Price action

20 metrics
Price change (1W)
+4.8%
Price change (30D)
-5.0%
Price change (3M)
-14.7%
Price change (6M)
-30.7%
Price change (YTD)
+17.0%
Price change (1Y)
-9.6%
Trailing year
Price change (5Y)
-85.3%
52-week high
$1.22
52-week low
$0.51
Change from 52-week high
-33.6%
Change from 52-week low
+60.5%
Annualized volatility
74.7%
Annualized volatility (3M)
59.6%
Beta
0.4
RSI (14D)
49.8
Price vs SMA 50
-3.7%
Price vs SMA 200
-16.4%
Avg volume (3M)
176,040
Relative volume
0.4
Average dollar volume
$143,267

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
44.29M

Valuation

12 metrics
P / E (TTM)
0.8
Trailing earnings · reciprocal yield 123.4%
PEG ratio
—
EV / revenue
4.7×
reciprocal yield 21.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 33.8%
P / book
2.3
reciprocal yield 43.9%
FCF yield
-128.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
144.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
57.8%
Operating margin
-214.8%
Trailing 12 months
Net margin
426.9%
Gross profit (TTM)
$7.01M
Operating profit (TTM)
−$26.07M
Net income (TTM)
$51.81M
Trailing 12 months
Diluted EPS (TTM)
$1.00
FCF margin
-379.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.27
Gross profit per diluted share (TTM)
$0.15
Operating profit per diluted share (TTM)
$-0.58
EBITDA per diluted share (TTM)
$-0.54
Net income per diluted share (TTM)
$1.06
Operating cash flow per diluted share (TTM)
$-0.96
Free cash flow per diluted share (TTM)
$-1.00
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$0.15
Stock compensation per diluted share (TTM)
$0.10
Book value per share
$-115.47

Growth

11 metrics
Revenue growth YoY
-11.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$12.14M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-19.8%
Revenue CAGR (5Y)
-22.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
329.0%
Return on assets
118.7%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
−$24.37M
Free cash flow (TTM)
−$46.03M
Quick ratio
1.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$21.38M
Latest balance sheet
Cash & equivalents
$19.90M
Total assets
$43.65M
Total debt
$26.10M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$43.99M
Capital expenditures (TTM)
$2.03M
R&D (TTM)
$6.80M
SG&A (TTM)
—
Stock compensation (TTM)
$4.69M
R&D / revenue
56.1%
Stock compensation / revenue
38.6%

Ownership (13F)

9 metrics
13F filers
39
13F filer change QoQ
+4
Institutional ownership
32.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-7.6%
Holder tenure
11.5
Price vs estimated holder cost
-65.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.4%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
28 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1708527 CUSIP 05479K106 13F (30d) 2 filings 2 filers Visit website Investor relations